PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)

CUSIP: 74587V107

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock
Shares outstanding
49,633,071
Total 13F shares
26,576,438
Share change
-1,279,215
Total reported value
$93,807,644
Put/Call ratio
14%
Price per share
$3.53
Number of holders
67
Value change
-$4,382,380
Number of buys
15
Number of sells
42

Security key

74587V107

Report period

Q2 2023

Institutions

67

Top holders

10

Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Camber Capital Management LP
13F
Company
8.5%
4,235,000
$13,086,000 31 Mar 2023
13F
VANGUARD GROUP INC
13F
Company
7.6%
3,771,345
$11,653,456 31 Mar 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
6%
2,985,835
$9,226,000 31 Mar 2023
13F
Eversept Partners, LP
13F
Company
3.9%
1,938,088
$5,988,692 31 Mar 2023
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
3.8%
1,874,859
$5,792,000 31 Mar 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
3.7%
1,834,913
$5,670,000 31 Mar 2023
13F
Athyrium Capital Management, LP
13F
Company
3.6%
1,792,114
$5,537,632 31 Mar 2023
13F
BlackRock Finance, Inc.
13F
Company
3.1%
1,518,942
$4,693,531 31 Mar 2023
13F
Hillsdale Investment Management Inc.
13F
Company
1.7%
834,103
$2,577,378 31 Mar 2023
13F
GLOBEFLEX CAPITAL L P
13F
Company
1.1%
561,530
$1,735,128 31 Mar 2023
13F
Kynam Capital Management, LP
13F
Company
0.95%
473,070
$1,461,786 31 Mar 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.93%
462,196
$1,428,186 31 Mar 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.91%
453,105
$1,400,095 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.79%
391,622
$1,210,111 31 Mar 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.77%
380,600
$1,176,054 31 Mar 2023
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.74%
367,497
$1,135,566 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
0.68%
339,895
$1,050,275 31 Mar 2023
13F
SEI INVESTMENTS CO
13F
Company
0.58%
286,060
$883,918 31 Mar 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.48%
236,375
$730,399 31 Mar 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.42%
208,149
$643,180 31 Mar 2023
13F
LSV ASSET MANAGEMENT
13F
Company
0.39%
194,551
$601,000 31 Mar 2023
13F
Assenagon Asset Management S.A.
13F
Company
0.39%
193,194
$596,969 31 Mar 2023
13F
FEDERATED HERMES, INC.
13F
Company
0.38%
191,063
$590,385 31 Mar 2023
13F
STATE STREET CORP
13F
Company
0.38%
188,599
$582,771 31 Mar 2023
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.37%
183,945
$568,390 31 Mar 2023
13F
Affinity Asset Advisors, LLC
13F
Company
0.36%
177,349
$548,008 31 Mar 2023
13F
MARSHALL WACE, LLP
13F
Company
0.35%
173,816
$537,091 31 Mar 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.3%
148,400
$458,556 31 Mar 2023
13F
Cubist Systematic Strategies, LLC
13F
Company
0.28%
138,178
$426,970 31 Mar 2023
13F
CORNERCAP INVESTMENT COUNSEL INC
13F
Company
0.25%
124,919
$386,000 31 Mar 2023
13F
Prospera Financial Services Inc
13F
Company
0.2%
100,072
$309,204 31 Mar 2023
13F
XTX Topco Ltd
13F
Company
0.16%
81,619
$252,203 31 Mar 2023
13F
Qube Research & Technologies Ltd
13F
Company
0.15%
76,685
$236,957 31 Mar 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.15%
74,004
$228,672 31 Mar 2023
13F
Bank of New York Mellon Corp
13F
Company
0.15%
73,363
$226,691 31 Mar 2023
13F
NORTHERN TRUST CORP
13F
Company
0.14%
69,841
$215,809 31 Mar 2023
13F
FMR LLC
13F
Company
0.13%
63,921
$197,516 31 Mar 2023
13F
MACQUARIE GROUP LTD
13F
Company
0.12%
61,255
$189,000 31 Mar 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.11%
53,153
$164,243 31 Mar 2023
13F
683 Capital Management, LLC
13F
Company
0.07%
36,500
$112,785 31 Mar 2023
13F
Patriot Financial Group Insurance Agency, LLC
13F
Company
0.07%
36,000
$111,240 31 Mar 2023
13F
Jump Financial, LLC
13F
Company
0.07%
34,900
$107,841 31 Mar 2023
13F
Crestline Management, L.P.
13F
Company
0.06%
31,884
$98,522 31 Mar 2023
13F
CAXTON ASSOCIATES LP
13F
Company
0.05%
24,610
$76,045 31 Mar 2023
13F
FRANKLIN RESOURCES INC
13F
Company
0.05%
24,234
$74,883 31 Mar 2023
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.05%
24,229
$74,868 31 Mar 2023
13F
PDT Partners, LLC
13F
Company
0.04%
21,946
$67,813 31 Mar 2023
13F
Walleye Capital LLC
13F
Company
0.04%
19,837
$61,296 31 Mar 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.04%
19,453
$60,110 31 Mar 2023
13F
Focus Partners Advisor Solutions, LLC
13F
Company
0.04%
19,220
$59,390 31 Mar 2023
13F

Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2023

As of 30 Jun 2023, PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,576,438 shares. The largest 10 holders included Camber Capital Management LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, Athyrium Capital Management, LP, RENAISSANCE TECHNOLOGIES LLC, Eversept Partners, LP, BlackRock Inc., Hillsdale Investment Management Inc., and GLOBEFLEX CAPITAL L P. This page lists 67 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
77
Q2 2023 holders
67
Holder diff
-10
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .